Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
Rang in aandelen
#4179
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Aandeelprijs
$2.29
Marktkapitalisatie
$3.83B
Verandering (1 dag)
3.06%
Verandering (1 jaar)
-6.38%
Land
CN
Handel Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Categorie
Healthcare
Winst voor Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Winst in Jun 2026 TTM: $246.26M
Volgens de meest recente financiële verslagen van Shijiazhuang Yiling Pharmaceutical Co., Ltd. bedraagt de huidige winst van het bedrijf $246.26M. In 2023 behaalde het bedrijf een winst van $237.93M, een daling ten opzichte van de winst van 2022, die $403.11M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Shijiazhuang Yiling Pharmaceutical Co., Ltd. van 2008 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $246.26M | -324.63% |
| 2024 | $-109.63M | -146.08% |
| 2023 | $237.93M | -40.98% |
| 2022 | $403.11M | 64.90% |
| 2021 | $244.45M | 12.26% |
| 2020 | $217.75M | 114.19% |
| 2019 | $101.66M | -0.25% |
| 2018 | $101.91M | 3.87% |
| 2017 | $98.11M | 8.63% |
| 2016 | $90.32M | 17.44% |
| 2015 | $76.90M | 16.02% |
| 2014 | $66.28M | 38.96% |
| 2013 | $47.70M | 37.56% |
| 2012 | $34.68M | -58.95% |
| 2011 | $84.47M | 51.19% |
| 2010 | $55.87M | 7.65% |
| 2009 | $51.90M | 145.52% |
| 2008 | $21.14M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $1.35B | 448.16% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $26.37M | -89.29% |
US
|
|
| - | - |
IT
|
